Nuvation Bio Acquires AnHeart: A Milestone in Oncology
Key Highlights Nuvation Bio to acquire AnHeart in an all-stock deal, with closing expected in Q2 2024, enhancing its…
Browsing Tag
AnHeart Therapeutics Ltd
1 post